India to United States: Ofloxacin Export Trade Route
India has recorded 992 verified shipments of Ofloxacin exported to United States, representing a combined trade value of $115.4M USD. This corridor is served by 51 active Indian exporters, with an average shipment value of $116.3K USD. The leading Indian exporter is DR.REDDY'S LABORATORIES LTD, which accounts for 26% of total export value with 62 shipments worth $30.3M USD. On the buying side, DR REDDYS LABORATORIES INC is the largest importer in United States with $31.0M USD in purchases. The top 3 suppliers — DR.REDDY'S LABORATORIES LTD, DR REDDYS LABORATORIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED — together control 63% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to United States Ofloxacin corridor is one of India's established pharmaceutical export routes, with 992 shipments documented worth a combined $115.4M USD. The route is dominated by DR.REDDY'S LABORATORIES LTD, which alone accounts for roughly 26% of all export value, reflecting the consolidated nature of India's ofloxacin manufacturing sector.
Across 51 active suppliers, the average shipment value stands at $116.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with ofloxacin's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 26.9%, placing it at rank #9 among India's top ofloxacin export destinations globally.
On the import side, key buyers of Indian ofloxacin in United States include DR REDDYS LABORATORIES INC, DR.REDDY'S LABORATORIES,INC, DR, REDDYS LABORATORIES, INC and 150 others. DR REDDYS LABORATORIES INC is the single largest importer with 26 shipments valued at $31.0M USD.
Route Characteristics
- Average transit22 days
- Peak seasonQ3
- Primary modeSea freight
- Top portDELHI AIR
Market Position
- Global rank#9
- Annual growth+26.9%
- Demand growth+24.4%
- Regulatory ease87/100
Top 10 Indian Ofloxacin Exporters to United States
Showing top 10 of 51 Indian suppliers exporting Ofloxacin to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LTD Avg $489.0K per shipment | 62 | $30.3M | 26.3% |
| 2 | DR REDDYS LABORATORIES LIMITED Avg $1.1M per shipment | 26 | $29.8M | 25.8% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $363.8K per shipment | 35 | $12.7M | 11.0% |
| 4 | MANKIND PHARMA LIMITED Avg $51.9K per shipment | 169 | $8.8M | 7.6% |
| 5 | AUROBINDO PHARMA LTD Avg $81.3K per shipment | 80 | $6.5M | 5.6% |
| 6 | FDC LIMITED Avg $51.8K per shipment | 96 | $5.0M | 4.3% |
| 7 | DR.REDDY'S LABORATORIES LIMITED Avg $235.8K per shipment | 19 | $4.5M | 3.9% |
| 8 | AUROBINDO PHARMA LIMITED Avg $72.3K per shipment | 44 | $3.2M | 2.8% |
| 9 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $896.9K per shipment | 3 | $2.7M | 2.3% |
| 10 | J B CHEMICALS AND PHARMACEUTICALS LIMITED Avg $30.1K per shipment | 89 | $2.7M | 2.3% |
This table shows the top 10 of 51 Indian companies exporting ofloxacin to United States, ranked by total trade value. The listed exporters are: DR.REDDY'S LABORATORIES LTD, DR REDDYS LABORATORIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, MANKIND PHARMA LIMITED, AUROBINDO PHARMA LTD, FDC LIMITED, DR.REDDY'S LABORATORIES LIMITED, AUROBINDO PHARMA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, J B CHEMICALS AND PHARMACEUTICALS LIMITED. DR.REDDY'S LABORATORIES LTD is the dominant supplier with 62 shipments worth $30.3M USD, giving it a 26% market share. The top 3 suppliers together account for 63% of the total trade value on this route.
Showing top 10 of 51 total Indian exporters on the India to United States Ofloxacin export route.
Top 10 Ofloxacin Importers in United States
Showing top 10 of 153 known buyers in United States receiving Ofloxacin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ofloxacin in United States include DR REDDYS LABORATORIES INC, DR.REDDY'S LABORATORIES,INC, DR, REDDYS LABORATORIES, INC, SUN PHARMACEUTICAL INDUSTRIES,INC., LIFESTAR PHARMA LLC, among 153 total buyers. The largest importer is DR REDDYS LABORATORIES INC, accounting for $31.0M USD across 26 shipments — representing 27% of all ofloxacin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DR REDDYS LABORATORIES INC | 26 | $31.0M | 26.8% |
| 2 | DR.REDDY'S LABORATORIES,INC | 14 | $10.5M | 9.1% |
| 3 | DR, REDDYS LABORATORIES, INC | 8 | $8.9M | 7.7% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES,INC. | 24 | $8.8M | 7.6% |
| 5 | LIFESTAR PHARMA LLC | 99 | $6.2M | 5.4% |
| 6 | SUN PHARMACEUTICAL INDUSTRIES INC | 13 | $6.1M | 5.2% |
| 7 | NORTHSTAR DISTRIBUTION CENTRE 8912 | 10 | $5.2M | 4.5% |
| 8 | DR REDDYS LABORATORIES,INC | 13 | $4.4M | 3.8% |
| 9 | Northstar Distribution Centre 8912 | 3 | $3.7M | 3.2% |
| 10 | AUROLOGISTICS LLC (AUROBINDO PHARMA | 39 | $3.4M | 2.9% |
Showing top 10 of 153 Ofloxacin importers in United States on this route.
Top 10 Ofloxacin Formulations Imported by United States
Showing top 10 of 543 product formulations shipped on the India to United States Ofloxacin route, ranked by trade value
United States imports a wide range of ofloxacin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1 — accounts for $19.4M USD across 16 shipments. There are 543 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1 | 16 | $19.4M | 16.8% |
| 2 | CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1% OTIC SUSPENSION USP 7.5ML BOTTLE | 12 | $15.6M | 13.6% |
| 3 | CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1 | 5 | $5.5M | 4.8% |
| 4 | CIPROFLOXACIN 0.3 AND DEXAMETHASONE 0.1%OTIC SUSPENSION USP 7.5ML BOTTLE (69360 NOS) | 1 | $3.6M | 3.1% |
| 5 | CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP,7.5ML- USA (BATCH NO AS PER INVOICE) | 8 | $2.8M | 2.4% |
| 6 | CIPROFLOXACIN (0.3%) AND DEXAMETHASONE (0.1%) STERILE OTIC SUSPENSION USP, 7.5ML- USA PACK : 01*01 (BATCH NO AS PER INV | 2 | $2.1M | 1.8% |
| 7 | CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1% STERILE OTIC SUSPENSION USP,7.5ML- USA PACK : 01*01 Batch No. As Per Invo | 1 | $2.0M | 1.7% |
| 8 | CIPROFLOXACIN 0 3 AND DEXAMETHASONE 0 1 OTIC SUSPENSION USP 7 5ML BOTTLE | 2 | $1.8M | 1.5% |
| 9 | CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1% OTIC SUSPENSION USP 7.5ML BOTTLE (46176 NOS) | 1 | $1.7M | 1.5% |
| 10 | CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1% OTIC SUSPENSION USP 7.5ML BOTTLE (45744 NOS)NOS | 3 | $1.7M | 1.4% |
Showing top 10 of 543 Ofloxacin formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 83%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR handles the highest volume with 151 shipments. Transit time averages 22 days by sea.
Market Dynamics
India's ofloxacin exports to United States are driven primarily by a handful of large-scale manufacturers. DR.REDDY'S LABORATORIES LTD with 62 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 51 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — DR.REDDY'S LABORATORIES LTD, DR REDDYS LABORATORIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED — together account for 63% of total trade value on this route. The average shipment value of $116.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension usp 7.5ml bottle and ciprofloxacin 0.3% and dexamethasone 0.1 , suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, DR REDDYS LABORATORIES INC is the largest importer with 26 shipments worth $31.0M USD — representing 27% of all ofloxacin imports from India on this route. A total of 153 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $115.4M
- Avg. Shipment
- $116.3K
- Suppliers
- 51
- Buyers
- 153
- Transit (Sea)
- ~22 days
- Annual Growth
- +26.9%
Reverse Direction
United States → India — Ofloxacin (Import)Other Ofloxacin Routes
Unlock the Full India to United States Ofloxacin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 992 shipments on this route.
Frequently Asked Questions — India to United States Ofloxacin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ofloxacin to United States?
The leading Indian exporters of Ofloxacin to United States are DR.REDDY'S LABORATORIES LTD, DR REDDYS LABORATORIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED. DR.REDDY'S LABORATORIES LTD holds the largest market share at approximately 26% of total trade value on this route.
Q What is the total value of Ofloxacin exports from India to United States?
India exports Ofloxacin to United States worth approximately $115.4M USD across 992 recorded shipments. The average value per shipment is $116.3K USD.
Q Which ports does India use to ship Ofloxacin to United States?
The most active port of origin is DELHI AIR with 151 shipments. Indian exporters primarily use sea freight for this route, with 83% of shipments going by sea and 28% by air.
Q How long does shipping take from India to United States for Ofloxacin?
The average transit time for Ofloxacin shipments from India to United States is approximately 22 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Ofloxacin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 26.9% with demand growth tracking at 24.4%. The route is ranked #9 among India's top Ofloxacin export destinations globally.
Q How many suppliers are active on the India to United States Ofloxacin route?
There are currently 51 active Indian suppliers exporting Ofloxacin to United States. The market is moderately concentrated with DR.REDDY'S LABORATORIES LTD accounting for 26% of total shipment value.
Q Who are the main importers of Ofloxacin from India in United States?
The leading importers of Indian Ofloxacin in United States include DR REDDYS LABORATORIES INC, DR.REDDY'S LABORATORIES,INC, DR, REDDYS LABORATORIES, INC, SUN PHARMACEUTICAL INDUSTRIES,INC., LIFESTAR PHARMA LLC. DR REDDYS LABORATORIES INC is the largest buyer with 26 shipments worth $31.0M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Ofloxacin.
- 2.Supplier/Buyer Matching: 51 Indian exporters and 153 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 992 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
992 Verified Shipments
51 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists